Nongfu Spring

According to Huxiu, Jinbo Biotech announced a revised private placement plan on September 28, reducing the maximum shares issued from 7.1757 million to 3.6072 million and cutting the total fundraising from up to 2 billion yuan to 1 billion yuan, while canceling an 850 million yuan supplementary liquidity project. On September 29, Jinbo Biotech’s stock closed up 0.81% at 128.66 yuan, with intraday volatility of 8.7%. Yangshengtang pledged to begin secondary-market purchases within 12 months and complete at least 1 billion yuan in buys within 18 months, with a non-transferable plan and a rare donation if the 18-month target is not met, irrevocably earmarked for FAST database and product development platform projects.